W3C Group Plans Ontology for Translational Medicine to Help Bridge Drug Discovery Phases
March 12, 2010
W3C Group Plans Ontology for Translational Medicine to Help Bridge Drug Discovery Phases
The World Wide Web Consortium's Health Care and Life Sciences Interest Group is plotting a semantic course to help find ways for pharma to communicate across drug discovery and development phases.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Movers & Shakers
August 19, 2011 / ProteoMonitor - Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
July 1, 2011 / ProteoMonitor - AstraZeneca to Open New Bioinformatics Center in St. Petersburg
June 24, 2011 / BioInform - IP Update
June 24, 2011 / BioInform - Kinaxo, Takeda Ink Second Collaboration for Phosphoproteomics Research
March 18, 2011 / ProteoMonitor